ONL Therapeutics

Ann Arbor, MI · Founded 2011 · Privately Held (backing)

Operator of a biopharmaceutical company intended to protect and improve patients' vision with various retinal diseases and conditions. ONL Therapeutics is based in Ann Arbor, MI and was founded in 2011. It has raised $133 million across 10 recorded rounds; the latest was a $60 million later-stage round in Sep 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$132.5M
Last round
Later Stage VC
Sep 2024
How much has ONL Therapeutics raised?
$132.5Macross 10 recorded rounds · Aug 2019 – Sep 2024

Most recently, ONL Therapeutics raised $60.0M in its Later Stage VC (Sep 2024).

Free account
More of ONL Therapeutics with a free account
  • ·The complete investor list: 26 names
  • ·Watch ONL Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

ONL Therapeutics round by round

10 rounds
Sep 2024Later Stage VC$60.0MSEC filing▮
35 investors participated
Feb 2024Early Stage VC$10.0MSEC filing▮
35 investors participated
Mar 2023Seed Round$5.0MSEC filing▮
30 investors participated
Dec 2020Early Stage VC$26.8MSEC filing▮
44 investors participated
Oct 2020Seed Round$2.0MSEC filing▮
3 investors participated
Aug 2019Seed Round$3.0MSEC filing▮
25 investors participated
+ 4 earlier rounds · a free account shows the full history

How much has ONL Therapeutics raised?

ONL Therapeutics has raised $133 million across 10 recorded rounds since 2014. The largest was a $10 million early-stage round in Feb 2024; the most recent was a $60 million later-stage round in Sep 2024.

ONL Therapeutics has filed 10 Form Ds with the SEC since 2014, most recently in Sep 2024 ($60 million sold to 35 investors).

ONL Therapeutics investors

26 investors are on record for ONL Therapeutics, including National Institutes of Health, Johnson & Johnson JJDC, Innovation Partnerships and Novartis Venture Fund. The later-stage round in Sep 2024 drew 35 investors.

For fundraisers
Raising for a company like ONL Therapeutics?

26 investors have backed ONL Therapeutics.

See all 26 investors →

Frequently asked about ONL Therapeutics

How much has ONL Therapeutics raised?
ONL Therapeutics has raised $132.5M in total across 10 recorded funding rounds.
When was ONL Therapeutics's last funding round?
ONL Therapeutics's most recent recorded round was Later Stage VC in Sep 2024, raising $60.0M.